Tofacitinib in a Recalcitrant Case of Alopecia Areata
December 2022
in “
Zenodo (CERN European Organization for Nuclear Research)
”
TLDR Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.
This article discusses a case of recalcitrant alopecia areata in a 14-year-old female who was successfully treated with oral tofacitinib. Alopecia areata is a non-cicatricial autoimmune disease characterized by smooth, round patches of hair loss. Tofacitinib is highlighted as a promising therapy for severe cases of alopecia areata, with increasing evidence supporting its efficacy. The case presented adds to the growing body of literature demonstrating the potential of tofacitinib in treating this condition.